Ron Perry

Member Spotlight

Ron Perry, Site Leader — Pfizer, Portage

MY BUSINESS…MYSELF

Pfizer is a 168-year-old American company founded in Brooklyn, NY and is proudly a U.S.-based corporation. We are one of the world’s premier innovative biopharmaceutical companies. In Pfizer Global Supply, we host 14 of our 58 Global Manufacturing sites in the U.S., where we employ about 11,000 of our 30,000 U.S.-based colleagues; more than any other country in the world.

In April, I was named Site Leader for Pfizer’s Portage site in Kalamazoo County, Michigan. Our largest global site, we have about 1,300 acres with over 4 million square feet of floor space, about 2,300 colleagues, and produce 150 drug products and active pharmaceutical ingredients for 113 global markets. Our biggest product is Solu-Medrol, a widely-used injectable anti-inflammatory medicine. The plant has been in operation since 1948, and Pfizer has had a presence in the community through the legacy Upjohn Company since 1886. We also have just about 100 colleagues located at our site in Rochester, Michigan.

I’ve been with Pfizer for more than 22 years, and previous led procurement for our global supply division. The majority of my career has been in manufacturing, starting in package engineering and then moving into supplier quality and procurement. My early experience was in the consumer goods industry, and I began my career with a defense industry firm providing supply chain solutions to the U.S. Navy.

THE FUTURE OF PFIZER IN MICHIGAN

Our future in Michigan is bright. On July 24, we announced we will increase our commitment to U.S. manufacturing with a $465 million investment to build one of the most technically advanced sterile injectable pharmaceutical production facilities in the world at our Portage site. This U.S. investment will strengthen Pfizer’s capability in Michigan to produce and supply critical, life-saving injectable medicines for patients globally. It also enhances employment opportunities in Kalamazoo and surrounding counties.

The new, multi-story, 400,000-square-foot production facility will also support the area economy by creating an estimated 450 new jobs over the next several years. For this site, we expect to invest approximately $1.1 billion – which is in addition to the $1 billion we have invested in the site over the past decade. Our new investments help us continue to deliver therapies that significantly improve people’s lives and to enhance our ability to bring medicines to the patients who need them.

GREATEST CHALLENGE

My perspective is that of a site leader. Our colleagues come to work with the aspiration to be considered most trusted by our patients, colleagues, regulators, and shareholders. That means that others count on us unconditionally to provide the needed therapies and life-saving medicines to our patients where they need them, and when they need them, reliably. Our challenge is to assure we can live up to this expectation, earn and maintain their trust by producing safe and efficacious medicines demanded of our Portage site. It is also important to continually assure we have a workforce that chooses to be with Pfizer and that they have a workplace that enables them to fulfill our mission.

GREATEST OPPORTUNITY

We are in a business of making drug products and therapies that give hope, make miracles, help a person’s condition, and that save lives. That’s what we do every day at our Michigan sites. Everyone has a role to play to assure we can continue being the most trusted company and strive to make a positive difference in the health and well-being of people everywhere. Our opportunities are many.

WHY PFIZER BELONGS TO THE CHAMBER

The Michigan Chamber is a strong partner and advocate for helping us make jobs possible and visible to those  who need them and create opportunities for greater growth and impact in our state. The Michigan Chamber is working every day in Lansing to ensure the state has a competitive business climate in today’s global economy. On issues such as workforce development, taxes, energy, regulation, and civil justice reform, we rely on the Chamber to fight for small businesses as well as global manufacturers like Pfizer.

A KEY TAKEAWAY

Every day, our colleagues come to work with the patient in mind and work hard to make a positive difference for all who rely on us.